Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Efficacy of ICPB in Thyroid Surgeries Using Two Bupivacaine Concentrations
NCT06621836Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jan 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Duration of analgesia at 24 hours. Started Jan 2025; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06621836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06621836.